Anterior Cruciate Ligament Reconstruction
Conditions
Interventions
Trade Name: Marcain Polyamp Steripak 0.25%
Product Name: Bupivacaine
Pharmaceutical Form: Injection*
Pharmaceutical form of the placebo: Injection*
Route of administration of the placebo: Other use
Sponsors
Derby Hospitals NHS Foundation Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients having primary anterior cruciate ligament reconstruction with ipsilateral hamstrings tendon graft, under spinal anaesthesia Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Patients unwilling to participate in the trial Those undergoing any procedure other than that detailed above Patients unable to consent for themselves Patients with known allergy to Bupivacaine Patients with peripheral neuropathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: To determine if hamstring graft donor site infiltration with local anaesthetic plus femoral nerve block provides better pain relief than femoral nerve block alone in patients having ipsilateral hamstrings tendon anterior curciate ligament reconstruction.;Secondary Objective: ;Primary end point(s): Pain relief in the region of the hamstrings during the first 24 hours post-operatively | — |
Countries
United Kingdom
Outcome results
None listed